News

ALTITUDE Study: Inappropriate ICD Shocks Don't Increase Mortality

Publish date: June 20, 2011

 

FROM THE ANNUAL MEETING OF THE HEART RHYTHM SOCIETY

Dr. Powell disclosed that he serves as a consultant to Boston Scientific, which sponsored ALTITUDE.

Pages

Recommended Reading

FDA: Simvastatin Dosing Changes to Reduce Muscle Toxicity Risk
MDedge Internal Medicine
Study Counters Link Between Intensive Therapy, Falls, and Fractures
MDedge Internal Medicine
Quality Guidelines Issued for Ambulatory Cardiac Care
MDedge Internal Medicine
Certain Antibodies Raise Rejection Risk in Heart Transplant Recipients
MDedge Internal Medicine
Simvastatin, Myalgias, and the QOD Solution
MDedge Internal Medicine
Ambulance Diversion Associated With Increased Heart Attack Mortality
MDedge Internal Medicine
Benefits of Perioperative Statins Borne Out in Trial
MDedge Internal Medicine
Aneurysm Complexity Influences Outcome
MDedge Internal Medicine
Fan Bids Cypher, the Sirolimus-Eluting Stent, Adieu
MDedge Internal Medicine
Fan Bids Cypher, the Sirolimus-Eluting Stent, Adieu
MDedge Internal Medicine